- Home
- ASTL vs IMTX Comparison
ASTL vs IMTX Comparison
Compare ASTL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTL
- IMTX
- Stock Information
- Founded
- ASTL 1902
- IMTX N/A
- Country
- ASTL Canada
- IMTX Germany
- Employees
- ASTL N/A
- IMTX N/A
- Industry
- ASTL Steel/Iron Ore
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASTL Industrials
- IMTX Health Care
- Exchange
- ASTL Nasdaq
- IMTX Nasdaq
- Market Cap
- ASTL 733.5M
- IMTX 653.9M
- IPO Year
- ASTL N/A
- IMTX N/A
- Fundamental
- Price
- ASTL $4.54
- IMTX $6.18
- Analyst Decision
- ASTL
- IMTX Strong Buy
- Analyst Count
- ASTL 0
- IMTX 4
- Target Price
- ASTL N/A
- IMTX $14.67
- AVG Volume (30 Days)
- ASTL 1.1M
- IMTX 340.1K
- Earning Date
- ASTL 08-18-2025
- IMTX 08-19-2025
- Dividend Yield
- ASTL 5.51%
- IMTX N/A
- EPS Growth
- ASTL N/A
- IMTX N/A
- EPS
- ASTL N/A
- IMTX N/A
- Revenue
- ASTL $1,679,424,123.00
- IMTX $155,801,989.00
- Revenue This Year
- ASTL N/A
- IMTX N/A
- Revenue Next Year
- ASTL $26.36
- IMTX $1.92
- P/E Ratio
- ASTL N/A
- IMTX N/A
- Revenue Growth
- ASTL N/A
- IMTX 93.56
- 52 Week Low
- ASTL $4.17
- IMTX $3.30
- 52 Week High
- ASTL $12.14
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- ASTL 20.34
- IMTX 49.01
- Support Level
- ASTL $5.05
- IMTX $6.19
- Resistance Level
- ASTL $6.32
- IMTX $6.66
- Average True Range (ATR)
- ASTL 0.31
- IMTX 0.30
- MACD
- ASTL -0.19
- IMTX -0.05
- Stochastic Oscillator
- ASTL 0.20
- IMTX 42.47
About ASTL Algoma Steel Group Inc.
Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.